XML 81 R68.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 6 Months Ended 30 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
segment
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2019
USD ($)
Financial information regarding the Company's reportable segments            
Number of reportable segments | segment     3      
Net sales $ 699,305 $ 742,661 $ 1,420,858 $ 1,487,121    
Acquisition related costs (3,592) (1,059) (5,866) (1,059)    
Total Restructuring Initiatives 7,331 1,737 12,170 11,267    
Depreciation and amortization 56,429 47,867 107,235 95,356    
Interest expense (8,734) (8,756) (17,122) (17,970)    
Interest income 175 1,033 350 2,781    
Income before Income Taxes 60,668 102,101 138,704 192,100    
Capital Expenditures     122,986 124,774    
Total Assets 3,814,016   3,814,016   $ 3,814,016 $ 3,562,119
Employee severance            
Financial information regarding the Company's reportable segments            
Total Restructuring Initiatives     8,190      
Business Transformation            
Financial information regarding the Company's reportable segments            
Total Restructuring Initiatives 7,300 1,700 12,200 11,300    
Capital Expenditures         $ 43,000  
Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 299,786 342,080 624,346 709,739    
Adjusted EBITDA 23,974 48,745 58,221 101,936    
Total Restructuring Initiatives 7,324 1,259 12,231 9,528    
Pharma            
Financial information regarding the Company's reportable segments            
Net sales 301,259 281,939 598,455 554,640    
Adjusted EBITDA 104,099 101,428 212,441 198,785    
Total Restructuring Initiatives (111) (113) (142) 213    
Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales 98,260 118,642 198,057 222,742    
Adjusted EBITDA 17,785 20,944 33,192 37,635    
Total Restructuring Initiatives 75 112 178 622    
Corporate & Other            
Financial information regarding the Company's reportable segments            
Adjusted EBITDA (9,279) (10,630) (23,107) (23,385)    
Total Restructuring Initiatives 43 479 (97) 904    
Operating segment            
Financial information regarding the Company's reportable segments            
Net sales 709,377 752,925 1,439,734 1,505,649    
Operating segment | Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 306,469 349,253 636,935 722,756    
Operating segment | Pharma            
Financial information regarding the Company's reportable segments            
Net sales 303,885 284,577 603,475 559,071    
Operating segment | Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales 99,023 119,095 199,324 223,822    
Intersegment            
Financial information regarding the Company's reportable segments            
Net sales 10,072 10,264 18,876 18,528    
Intersegment | Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 6,683 7,173 12,589 13,017    
Intersegment | Pharma            
Financial information regarding the Company's reportable segments            
Net sales 2,626 2,638 5,020 4,431    
Intersegment | Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales $ 763 $ 453 $ 1,267 $ 1,080